The abstract is read at the publisher; the summary is JClub's.
Pyroptosis-dominant programmed cell death subtype (PCD-P) is linked to the most favorable immunotherapy outcomes across multiple cancer types, within five conserved PCD subtypes.
- Why it matters: Molecular subtyping could unify precision oncology, but tumor heterogeneity and therapy response remain hard to interpret without a framework capturing programmed cell death patterns.
- What they did: The study integrated multi-cohort transcriptomic data across cancer types, used nonnegative matrix factorization to define five conserved PCD subtypes, and built a 20-gene classifier to assign them.
- The result: Subtypes showed distinct genomic alterations, cellular stresses, malignant traits, prognostic outcomes, and immune landscapes, enabling candidate subtype-specific therapeutic strategies pending future efficacy and toxicity testing.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.